MIR34Aregulates autophagy and apoptosis by targetingHMGB1in the retinoblastoma cell
- 3 January 2014
- journal article
- Published by Informa UK Limited in Autophagy
- Vol. 10 (3), 442-452
- https://doi.org/10.4161/auto.27418
Abstract
MIR34A (microRNA 34a) is a tumor suppressor gene, but how it regulates chemotherapy response and resistance is not completely understood. Here, we show that the microRNA MIR34A-dependent high mobility group box 1 (HMGB1) downregulation inhibits autophagy and enhances chemotherapy-induced apoptosis in the retinoblastoma cell. HMGB1 is a multifaceted protein with a key role in autophagy, a self-degradative, homeostatic process with a context-specific role in cancer. MIR34A inhibits HMGB1 expression through a direct MIR34A-binding site within the HMGB1 3′ untranslated region. MIR34A inhibition of HMGB1 leads to a decrease in autophagy under starvation conditions or chemotherapy treatment. Inhibition of autophagy promotes oxidative injury and DNA damage and increases subsequent CASP3 activity, CASP3 cleavage, and PARP1 [poly (ADP-ribose) polymerase 1] cleavage, which are important to the apoptotic process. Finally, upregulation of MIR34A, knockdown of HMGB1, or inhibition of autophagy (e.g., knockdown of ATG5 and BECN1) restores chemosensitivity and enhances tumor cell death in the retinoblastoma cell. These data provide new insights into the mechanisms governing the regulation of HMGB1 expression by microRNA and their possible contribution to autophagy and drug resistance.Keywords
This publication has 59 references indexed in Scilit:
- PAMPs and DAMPs: signal 0s that spur autophagy and immunityImmunological Reviews, 2012
- microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in GlioblastomaCancer Discovery, 2012
- MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosisAutophagy, 2012
- Deconvoluting the context-dependent role for autophagy in cancerNature Reviews Cancer, 2012
- p53/HMGB1 Complexes Regulate Autophagy and ApoptosisCancer Research, 2012
- RetinoblastomaThe Lancet, 2012
- Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cellsLeukemia, 2012
- HMGB1: A multifunctional alarmin driving autoimmune and inflammatory diseaseNature Reviews Rheumatology, 2012
- HMGB1 Promotes Drug Resistance in OsteosarcomaCancer Research, 2012
- Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cellsLeukemia & Lymphoma, 2011